SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)
Marie-Léa Gauci, Clélia Coutzac, Roch Houot, Aurélien Marabelle, Célèste Lebbé
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CancerImmunotherapy2019-20 coronavirus outbreakCancer immunotherapyIntensive care medicineSars virusImmunologyVirologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsCancer Immunotherapy and Biomarkers